Related Experiment Video
Updated: Apr 16, 2026
09:37
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
Published on: October 26, 2009
37.8K
Dextran-based hydrogel formed by thiol-Michael addition reaction for 3D cell encapsulation.
Zhen Qi Liu1, Zhao Wei1, Xv Long Zhu2
1School of Science, State Key Laboratory for Mechanical Behaviour of Materials, Collaborative Innovation Center of Suzhou Nano Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China; Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an 710049, China.
Colloids and Surfaces. B, Biointerfaces
|March 7, 2015
Summary
A new dextran-based hydrogel (Dex-l-DTT) was developed for cell encapsulation. This biomaterial supports cell viability and differentiation, showing promise for tissue engineering and transplantation therapies.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Three-dimensional (3D) hydrogels are crucial for mimicking the native cell microenvironment in cell-based therapies.
- Developing advanced hydrogels is essential for improving the efficacy of transplantation treatments.
Purpose of the Study:
- To develop a novel in situ-forming hydrogel system for enhanced cell encapsulation.
- To investigate the tunable properties and cell compatibility of the new hydrogel for biomedical applications.
Main Methods:
- Synthesized Dex-l-DTT hydrogel via thiol-Michael addition between glycidyl methacrylate derivatized dextran (Dex-GMA) and dithiothreitol (DTT).
- Investigated hydrogel properties (mechanical, gelation, swelling) by adjusting pH in phosphate-buffered saline.
- Demonstrated 3D cell encapsulation of rat bone marrow mesenchymal stem cells (BMSCs) and NIH/3T3 fibroblasts.
Main Results:
- The Dex-l-DTT hydrogel formed in situ under physiological conditions.
- Hydrogel properties were tunable by altering pH.
- High cell viability was maintained for encapsulated BMSCs and fibroblasts.
- Encapsulated BMSCs retained their differentiation potential.
Conclusions:
- The Dex-l-DTT hydrogel offers a promising platform for 3D cell encapsulation.
- Its tunable properties and biocompatibility support its potential use in the biomedical field, particularly for cell-based therapies.
